Dear gustavo.braslavsky.clinical,
We are looking for employees working remotely.
My name is Toby, I am the personnel manager of a large International company.
Most of the work you can do from home, that is, at a distance.
Salary is $2300-$5900.
If you are interested in this offer, please visit Our Site
d_health Good day!
Clinical Trials News
Latest News About Clinical Research . Clinical Trials Online Course
Re: Salary [$1000 /week]
Security status not satisfied.
I was planning to say hello, but now I think greetings are unnecessary.
Firstly, I already know you and all your loved ones very well.
Secondly, the occasion for which I'm writing to you is not the happiest one for a friendly greeting.
You've heard that the Internet is a dangerous place, infested with malicious links and hackers like me?
Of course, you've heard, but what's the point in it if you are so dismissive of your internet security and don't care what websites you visit?
Times have changed. You read about AI, judging by your browser history, and still didn't understand anything?
Technologies have stepped far forward, and now hackers like me use artificial intelligence.
Thanks to it, I can get not only access to your webcam and record your fun with highly controversial video
(I recorded it also, but now that's not the point), but also to all your devices and not only yours.
And I saved a special sauce for this dish. I went further and sent malicious links to all your contacts from your account.
Yes, someone was smarter and realized that this was a trap and you were hacked, but believe me,
about 70% of your contact list (and these are your friends, colleagues, and family) bought into my scam.
They have as many skeletons in their closet as you do. Some turn out to be hidden homosexuals...
I have accumulated and analyzed a huge amount of compromising data on you and those with whom you communicate.
Very soon I'll start a crossfire - everyone will receive the full history of correspondence
(and there are enough of "sensitive moments") and recordings from the other contact's webcam.
I can go further and put all these files, as well as the recorded fun of you and your hacked contacts with "hardcore videos" into the public domain.
You can imagine, it will be a real sensation!
And everyone will understand where it came from - from you.
For all your contacts and, you will be enemy number one. Even your relatives will take a long time to forgive you and forget such a family shame...
It will be the real end of the world. The only difference is that there will be not four horsemen of the apocalypse, but only one - (=
But there is no such thing as a completely black stripe without any white dots.
Luckily for you, in my case the "Three M Rule" comes into play - Money, Money and Money again.
I'm not interested in your worthless life, I'm interested in people from whom I can profit.
And today you are one of them.
That's why: Transfer $1390 in Bitcoin to: 1PPJpvSPbbMwbESJZXGS8VtKiFQkmm7DvK ...within 48 hours!
You don't know how to use cryptocurrencies? Use Google, everything is simple.
Once payment is received, I will delete all information associated with you and you will never hear from me again.
Remember one thing: my crypto address is anonymous, and I generated this letter in your mailbox and sent it to you.
You can call the cops, do whatever you want - they won't find me, my demands won't change, but you'll just waste precious time.
The clock is ticking. Tick tock, a minute out of 48 hours has passed right now. An hour will soon pass, and in two days your old life will pass forever.
Either goodbye forever (if I get my payment), or hello to a brave new world in which there will be no place for you.
Hasta La Vista, Baby!
P.S. Almost forgot. Finally learn what incognito tabs, two-factor authentication, and the TOR browser are, for God's sake!
«Наглядно: плюсы и минусы ручной торговли в циклическом трейдинге» в группе «Легкие деньги в трейдинге циклами»
«Наглядно: плюсы и минусы ручной торговли в циклическом трейдинге» в группе «Легкие деньги в трейдинге циклами»
|
Biomarker predicts TIL therapy success against eye cancer
What matters in cancer |
| |||||
| |||||
Hello Nature readers, | |||||
Around 5% of all tumours have no known organ of origin. People with these types of cancers have poor survival rates unless the location of the primary tumour is discovered. (Steve Gschmeissner/Science Photo Library) | |||||
AI traces mysterious cancers to their sourceAn algorithm could take the guesswork out of treating metastatic cancers by predicting the location of primary tumours. Cancer cells are stamped with identifying features based on the organ where the cancer first emerged. Researchers trained an artificial intelligence (AI) to recognise these features using images of cancer cells extracted from the abdominal or lung fluid of people whose primary-tumour locations were known. When tested on around 27,000 images, the algorithm had an 83% chance of correctly predicting the organ where the cancer had first emerged and a 99% chance of having the right answer in its top three predictions. People who had been treated in accordance with the algorithm's predictions lived longer than those that were not (27 versus 17 months). Nature | 3 min readReference: Nature Medicine paper (16 April) | |||||
How aspirin helps the body fight cancerAspirin seems to protect against the spread of colorectal cancer by enhancing the anticancer immune response. In a study of 238 people with colorectal cancer, the 12% of participants who took daily, low-dose aspirin to prevent heart disease had more cancer-fighting immune cells inside their tumours, more biomarkers relating to immunosurveillance and a lower chance of the cancer spreading to their lymph nodes than those that had not taken aspirin. Taking aspirin is associated with a lower risk of colorectal cancer, "but it has to be balanced with the risks", which include gastrointestinal bleeding, says oncologist Jeff Meyerhardt. National Geographic | 5 min readReference: Cancer paper (22 April) | |||||
Biomarker predicts TIL therapy successResearchers have developed a clinical tool for predicting whether people with a rare type of eye cancer called uveal melanoma will respond to tumour-infiltrating lymphocyte (TIL) therapy. Researchers measured gene activity in 100 tumour samples taken from 84 people with uveal melanoma and identified a biomarker that predicted whether patients would benefit from TIL therapy. More than half of the tumours examined contained TILs — however, previous research shows that only around 35% of people with this disease respond to TIL therapy. The Washington Post | 5 min readReference: Nature Communications paper (16 April) | |||||
In the news
| |||||
| |||||
Olaparib no good for breast-cancer subsetPeople with breast cancer who lack common receptors and have no BRCA gene mutations do not live longer when treated with the targeted drug olaparib compared with a control group. In a clinical trial of 559 people with triple-negative breast cancer and no BRCA gene mutations, those given olaparib plus chemotherapy had the same response and survival rates as those given chemotherapy alone. This was in "marked contrast to the major benefit of olaparib" in people with BRCA gene mutations who were assessed in a separate study, write the authors. Reference: Nature paper (8 April) | |||||
Childhood cancer increases biological ageingPeople who survive childhood cancer age 5% faster each year than their cancer-free peers, leading to a greater risk of premature frailty and death. In a study of more than 4,700 people, child-cancer survivors had biologically aged 5-16 years more than people who never had cancer. Nature Research Highlight | 1 min readReference: Nature Cancer paper (29 March) | |||||
| |||||
'You are peeing differently'Media executive Ed Manning was diagnosed with prostate cancer after his wife noticed a change in his bathroom habits. "You are peeing differently," she said. "The bathroom door isn't soundproof and it sounds like things take longer to get going. You need to tell your doctor. It could mean something." Manning now wishes his doctors had done more than simply conducting an annual prostate check. "I wish that in addition to the cursory 'looks good' I had heard over the years, they had provided salient details about my prostate, warning signs and testing options," he says. CNN | 6 min read | |||||
| |||||
RAS proteins are mutated in many types of cancer, but these mutations play a particularly prominent role in pancreatic and colorectal cancers. See a larger version of this image here. (Nature Reviews Cancer | 9 min read) (Anupriya Singhal et al/Nature Medicine) | |||||
Quote of the week"As we drift across the map of our days, moving towards the darkness at the edge, it can help every now and then to look up and remind ourselves that the darkness is always there and always waiting, and we should enjoy the warm light of day while it remains ours to enjoy."After his third melanoma diagnosis in five years, author John Birmingham is sharing some hard-won life lessons. (Substack | 4 min read) | |||||
| |||||
| |||||
| |||||
Want more? Update your preferences to sign up to our other free Nature Briefing newsletters:
| |||||
ACCESS NATURE AND 54 OTHER NATURE JOURNALS Nature+ is our most affordable 30-day subscription, giving you online access to a wide range of specialist Nature Portfolio journals, including Nature. Nature+ is for personal use and is suitable for students. | |||||
| |||||
You received this newsletter because you subscribed with the email address: gustavo.braslavsky@gmail.com Please add cancerbriefing@nature.com to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? To unsubscribe from this Briefing, but keep receiving your other Nature Briefing newsletters, please update your subscription preferences. To stop all Nature Briefing emails forever, click here to remove your personal data from our system. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Portfolio journals. Nature Portfolio | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Portfolio, part of Springer Nature. |
Don't miss today's event: Lifestyle Interventions in the Management of Obesity
|
Visit the Gastric Cancer Knowledge Hub today
|